Net income surged 73.3% year-over-year, with strong premium growth and improved loss ratios. Dividend and buyback plans underscore a focus on shareholder value, while international and health segments showed robust expansion.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.